About Acadia
We take on some of the toughest challenges in neuroscience and rare disease to deliver innovative and vital solutions to people who need them most.
We take on some of the toughest challenges in neuroscience and rare disease to deliver innovative and vital solutions to people who need them most.

Driven by the needs of underserved communities, we combine bold science with real-world insights to bring forward therapies others may overlook. Addressing complex neurological disorders and rare diseases requires more than treatments alone; it also means delivering meaningful innovation alongside the resources, tools, and support that empower patients, caregivers, and families to experience lasting improvements in their daily lives. This commitment is reflected in our values:
We developed and commercialized the first and only FDA-approved drug to treat hallucinations and delusions associated with Parkinson’s disease psychosis and the first and only approved drug in the United States and Canada for the treatment of Rett syndrome. We are working with health authorities outside of the U.S. and Canada to seek approvals of our treatment option for people living with Rett syndrome.

Our clinical-stage development efforts are focused on Prader-Willi syndrome, Alzheimer’s disease psychosis, essential tremor, and multiple other programs targeting neuropsychiatric symptoms in central nervous system disorders.

We are seeking individuals with diverse skills, experiences, and backgrounds to join our growing team. Headquartered in San Diego, California, with a presence across Europe, the United States, and Canada, we are building a world-class organization dedicated to improving lives and elevating the standard of care in neuroscience and rare disease.

Collaboration is key to our success. We are dedicated to partnering with organizations, companies, and individuals to help develop therapies to treat rare diseases and disorders of the central nervous system.
We welcome the opportunity to learn how we can work together. To explore partnering opportunities, please contact Acadia Business Development at bd@acadia-pharm.com.
